Melanocyte lineage-specific antigen gp100
Showing 1 - 25 of >10,000
HIV-1-infection Trial in Amsterdam (ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes)
Active, not recruiting
- HIV-1-infection
- ConM SOSIP.v7 gp140, adjuvanted with MPLA liposomes
-
Amsterdam, Noord-Holland, NetherlandsAmsterdam University Medical Centers, location AMC
Jan 31, 2023
Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19
Recruiting
- Lymphoblastic Leukemia
- +5 more
- Anti-CD19 CAR T-cells
-
Singapore, Singapore
- +1 more
Dec 4, 2022
Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia in Children Trial in Singapore (Phase
Recruiting
- Lymphoblastic Leukemia
- +4 more
- Phase I
- Phase II
-
Singapore, SingaporeKK Women's and Children's hospital
Jun 20, 2022
Melanoma Trial in Houston (gp100, R848 gel, MAGE-3)
Completed
- Melanoma
- gp100
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jul 20, 2021
Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))
Recruiting
- Hematologic Malignancy
- Myeloid Malignancy
- Ruxolitinib
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 7, 2022
Antigen-specific T Cells in Antisynthetase Syndrome and
Not yet recruiting
- Antisynthetase Syndrome
- BAL antigen-specific Th1 cells and Th17 cells, ILC and MAIT
-
Dijon, France
- +5 more
Aug 2, 2023
Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow
Recruiting
- Inherited BMF Syndrome
- The whole-exome sequencing
-
Sohag, Egypt, Faculty of Medicine, Sohag University
Jun 28, 2022
Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)
Not yet recruiting
- Prostate Adenocarcinoma
- 68-Ga PSMA11
-
Dallas, TexasUT Southwestern Medical Center
Sep 12, 2023
Optic Neuromyelitis Spectrum Disease Trial in China (BAT4406F Injection, BAT4406F Placebos)
Recruiting
- Optic Neuromyelitis Spectrum Disease
- BAT4406F Injection
- BAT4406F Placebos
-
Baotou, China
- +44 more
Sep 12, 2023
Hepatocellular Carcinoma Trial (IPM001)
Not yet recruiting
- Hepatocellular Carcinoma
- IPM001
- (no location specified)
Sep 7, 2022
dapted Strategy Including Magnetic Resonance Imaging and
Completed
- Prostate Cancer
- Prostate Adenocarcinoma
-
Ankara, TurkeyAnkara University School of Medicine
Sep 6, 2023
Vitiligo Trial in Cairo (Narrow band UVB)
Active, not recruiting
- Vitiligo
- Narrow band UVB
-
Cairo, El Manial, EgyptKasr El Ainy university hospital, Faulty of medicine,Cairo unive
Mar 10, 2022
Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)
Recruiting
- Malignancy
- Al18F-PSMA-BCH PET/CT
-
Beijing, Chaoyang, ChinaNational Cancer Center/Cancer Hospital,Chinese Academy of Medica
Mar 7, 2023
HIV Trial in Rochester (MTP-PE/MF59, Env 2-3)
Completed
- HIV Infections
- MTP-PE/MF59
- Env 2-3
-
Rochester, New YorkUniv. of Rochester AVEG
Oct 27, 2021
Acute Leukemia of Ambiguous Lineage Trial in Suzhou (Venetoclax, azactidine)
Recruiting
- Acute Leukemia of Ambiguous Lineage
-
Suzhou, ChinaThe First Affliated Hospital of Soochow University
Jun 14, 2023
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle
Not yet recruiting
- Castration-Resistant Prostate Carcinoma
- +2 more
- Biopsy
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Nov 17, 2023
Leukemia, T Cell Trial in Beijing (CD7 CART)
Recruiting
- Leukemia, T Cell
- CD7 CART
-
Beijing, Hebei, ChinaHe bei Yan da Lu dao pei Hospital
May 24, 2022
Cancer, Immune System or Toxicities Suspected Trial in Paris, Saint-Cloud (blood sample)
Recruiting
- Cancer
- Immune System or Toxicities Suspected
- blood sample
-
Paris, France
- +1 more
Sep 16, 2022
Progressive Metastatic Prostate Cancer Trial in Worldwide (Enzalutamide, Placebo)
Active, not recruiting
- Progressive Metastatic Prostate Cancer
- Enzalutamide
- Placebo
-
Beijing, China
- +46 more
Jan 13, 2023
Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston
Not yet recruiting
- Advanced Prostate Cancer
- +2 more
- 18F-fluciclovine
- PET/CT
-
Boston, Massachusetts
- +1 more
Sep 25, 2023